Remarkable response of BRAF^(V600E)-mutated metastatic pancreatic cancer to BRAF/MEK inhibition:a case report 被引量：1

导出

摘要 Introduction Advanced pancreatic ductal adenocarcinoma(PDAC)has very limited treatment options due to few targetable mutations,and chemotherapeutic treatment is currently the mainstay of palliative therapy for PDAC patients.

作者 Hong-Shuai Li Ke Yang Yan Wang

机构地区 Department of Medical Oncology Department of Medical Oncology

出处《Gastroenterology Report》 SCIE EI 2022年第1期615-617,共3页 胃肠病学报道（英文）

基金 supported by the Chinese Academy of Medical Sciences(CAMS)Innovation Fund for Medical Sciences(CIFMS)[2019-I2M-2-003] Chinese Society of Clinical Oncology(CSCO)-Hengrui Research Funding[Y-HR2018-239].

关键词 V600E BRAF ADENOCARCINOMA

分类号 R735.9 [医药卫生—肿瘤]

引文网络
相关文献

同被引文献4

1Changfa Xia,Xuesi Dong,He Li,Maomao Cao,Dianqin Sun,Siyi He,Fan Yang,Xinxin Yan,Shaoli Zhang,Ni Li,Wanqing Chen.Cancer statistics in China and United States,2022:profiles,trends,and determinants[J].Chinese Medical Journal,2022(5):584-590. 被引量：1571
2Xi Wang,Cheng-Sheng Zhang,Xu-Yuan Dong,Yuan Hu,Bao-Jun Duan,Jun Bai,Yin-Ying Wu,Lin Fan,Xin-Hua Liao,Ye Kang,Peng Zhang,Meng-Yang Li,Jiao Xu,Zhi-Jun Mao,Hui-Tong Liu,Xiao-Long Zhang,Li-Fei Tian,En-Xiao Li.Claudin 18.2 is a potential therapeutic target for zolbetuximab in pancreatic ductal adenocarcinoma[J].World Journal of Gastrointestinal Oncology,2022,14(7):1252-1264. 被引量：1
3杨尹默,董睿涵,张兴胜,马永蔌.“死亡荒漠”的“绿洲”:重视微卫星高度不稳定/错配修复缺陷胰腺癌的诊断与治疗[J].中华消化外科杂志,2023,22(5):588-592. 被引量：1
4陈博滔,毛先海.胰腺癌免疫治疗临床研究进展[J].中华消化外科杂志,2023,22(5):610-615. 被引量：4

引证文献1

1胡润,李俊蒽,姚沛,桂仁捷,段华新.不可切除胰腺癌的分子靶向药物治疗进展[J].临床肝胆病杂志,2024,40(2):426-432.

1Panayiotis Hadjicostas,Demetris Christou,Anastasios Christodoulou.Radiofrequency Ablation of Pancreatic Ductal Adenocarcinoma: An Evolving Comrade?[J].Journal of Cancer Therapy,2016,7(13):1071-1081.
2Li-Rong Wei,Yun Liu,Xiao-Feng Liu,Ya-Nan Wang,Shen Wang.The effect of advance care planning in patients with dementia: a protocol of systematic review and meta-analysis[J].Aging Communications,2022,4(1):23-27.
3Amaninder Dhaliwal,Syed M Saghir,Harmeet S Mashiana,Annie Braseth,Banreet S Dhindsa,Daryl Ramai,Pushpak Taunk,Rene Gomez-Esquivel,Aamir Dam,Jason Klapman,Douglas G Adler.Endoscopic cryotherapy:Indications,techniques,and outcomes involving the gastrointestinal tract[J].World Journal of Gastrointestinal Endoscopy,2022,14(1):17-28.
4Weifeng Zeng,Ruiqi Mao,Zhanguo Zhang,Xiaoping Chen.Combination Therapies for Advanced Biliary Tract Cancer[J].Journal of Clinical and Translational Hepatology,2023,11(2):490-501. 被引量：4
5Hao Fan,Hongmei Duan,Peng Hao,Yudan Gao,Wen Zhao,Fei Hao,Xiaoguang Li,Zhaoyang Yang.Cellular regeneration treatments for traumatic brain injury[J].Medicine in Novel Technology and Devices,2022(4):285-292.
6Yan-Wei Chen,Hai-Zhen Yang,Shuang-Shuang Zhao,Zheng Zhang,Zhe-Ming Chen,Hua-Hui Feng,Mao-Hui An,Ke-Ke Wang,Ran Duan,Bao-Ding Chen.Ultrasound-guided microwave ablation as a palliative treatment for mycosis fungoides eyelid involvement:A case report[J].World Journal of Clinical Cases,2022,10(17):5825-5832.
7Wenjun Xiong,Xiaohua Zhong,Yan Chen,Sijing Luo,Yaohui Peng,Yuanfa Hou,Jin Li,Yansheng Zheng,Lijie Luo,Ziming Cui,Wei Wang.A novel surgical technique for dissection of Siewert typeⅡadenocarcinoma of the esophagogastric junction:the transthoracic single-port assisted laparoscopic esophagogastrostomy[J].Gastroenterology Report,2022,10(1):625-627. 被引量：2
8Periklis Zavridis,Maria Tsitskari,Argyro Mazioti,Dimitrios Filippiadis.Percutaneous, computed tomography guided neurolysis using continuous radiofrequency for pain reduction in oncologic patients[J].Journal of Cancer Metastasis and Treatment,2017,3(1):60-64.
9Amir Kashani,Jonathan C.Ellis,Melissa Kahn,Laith H.Jamil.Liver metastasis from hepatoid adenocarcinoma of the esophagus mimicking hepatocellular carcinoma[J].Gastroenterology Report,2017,5(1):67-71. 被引量：1
10C.P.Yi,E.Nordlund,P.Zhang,S.Warema,S.Shirzadegan.Numerical modeling for a simulated rockburst experiment using LS-DYNA[J].Underground Space,2021,6(2):153-162. 被引量：5

Gastroenterology Report

2022年第1期

浏览历史

内容加载中请稍等...

Remarkable response of BRAF^(V600E)-mutated metastatic pancreatic cancer to BRAF/MEK inhibition:a case report 被引量：1

同被引文献4

引证文献1

相关作者

相关机构

相关主题

浏览历史